Ingemar Kvarnström

1.8k citations

64 papers · 1.4k indexed · h-index 23

Organic Chemistry top 2%
Molecular Biology top 10%
Infectious Diseases top 5%
Plant Science top 10%
Computational Theory and Mathematics top 5%

Co-authors: Per J. Garegg Bertil Samuelsson Björn Classon Bengt Lindberg Stefan C. T. Svensson Anders Hallberg U. Helena Danielson Anders Karlén
Topics: HIV/AIDS drug development and treatment (30 papers)Carbohydrate Chemistry and Synthesis (23 papers)HIV Research and Treatment (19 papers)
Cited by: Organic Chemistry Virology Infectious Diseases
Journals: Proceedings of the National Academy of Sciences Journal of Medicinal Chemistry The Journal of Organic Chemistry
Partner nations: Sweden Canada Germany

In The Last Decade

Ingemar Kvarnström

64 papers receiving 1.4k citations

Peers

Countries citing papers authored by Ingemar Kvarnström

Since Specialization

Citations

This map shows the geographic impact of Ingemar Kvarnström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingemar Kvarnström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingemar Kvarnström more than expected).

Fields of papers citing papers by Ingemar Kvarnström

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingemar Kvarnström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingemar Kvarnström. The network helps show where Ingemar Kvarnström may publish in the future.

Co-authorship network of co-authors of Ingemar Kvarnström

This figure shows the co-authorship network connecting the top 25 collaborators of Ingemar Kvarnström. A scholar is included among the top collaborators of Ingemar Kvarnström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingemar Kvarnström. Ingemar Kvarnström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design and Synthesis of Novel Arylketo-containing P1-P3 Linked Macro-cyclic BACE-1 Inhibitors 2015 ·PubMed ·(unknown),Oscar Belda,Ingemar Kvarnström,Jimmy Lindberg,Bertil Samuelsson,(unknown)	1
2	Highly potent macrocyclic BACE-1 inhibitors incorporating a hydroxyethylamine core: Design, synthesis and X-ray crystal structures of enzyme inhibitor complexes 2012 ·Bioorganic & Medicinal Chemistry ·(unknown),Tatiana Agback,Per-Ola Johansson,Jimmy Lindberg,Ingemar Kvarnström,Bertil Samuelsson,Oscar Belda,(unknown)	23
3	Synthesis of potent BACE-1 inhibitors incorporating a hydroxyethylene isostere as central core 2009 ·European Journal of Medicinal Chemistry ·(unknown),Karin Gustafsson,Ingemar Kvarnström,Neera Borkakoti,Michael Edlund,Katarina Jansson,Jimmy Lindberg,Anders Hallberg,Åsa Rosenquist,Bertil Samuelsson	19
4	Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: Exploration of P1 phenoxy and benzyloxy residues 2008 ·Bioorganic & Medicinal Chemistry ·Marcus Bäck,Jonas Nyhlén,Ingemar Kvarnström,(unknown),Neera Borkakoti,Katarina Jansson,Jimmy Lindberg,Susanne Nyström,Anders Hallberg,Åsa Rosenquist,Bertil Samuelsson	25
5	Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: Use of cyclopentane and cyclopentene P2-motifs 2007 ·Bioorganic & Medicinal Chemistry ·Marcus Bäck,Per-Ola Johansson,(unknown),(unknown),Ingemar Kvarnström,(unknown),(unknown),(unknown),Katarina Jansson,Stefan B. Lindström,Hans Wallberg,Björn Classon,(unknown),Lotta Vrang,Elizabeth Hamelink,Anders Hallberg,Åsa Rosenquist,Bertil Samuelsson	19
6	Potent inhibitors of the hepatitis C virus NS3 protease: Use of a novel P2 cyclopentane-derived template 2006 ·Bioorganic & Medicinal Chemistry ·Per-Ola Johansson,Marcus Bäck,Ingemar Kvarnström,Katarina Jansson,Lotta Vrang,Elizabeth Hamelink,Anders Hallberg,Åsa Rosenquist,Bertil Samuelsson	13
7	Synthesis of novel potent hepatitis C virus NS3 protease inhibitors: Discovery of 4-hydroxy-cyclopent-2-ene-1,2-dicarboxylic acid as a N-acyl-l-hydroxyproline bioisostere 2006 ·Bioorganic & Medicinal Chemistry ·(unknown),(unknown),Ingemar Kvarnström,Lotta Vrang,Elizabeth Hamelink,Katarina Jansson,Anders Hallberg,Åsa Rosenquist,Bertil Samuelsson	8
8	Symmetric fluoro‐substituted diol‐based HIV protease inhibitors 2004 ·European Journal of Biochemistry ·Jimmy Lindberg,(unknown),(unknown),Åsa Rosenquist,Guido Zuccarello,Ingemar Kvarnström,Hong Zhang,Lotta Vrang,Björn Classon,Anders Hallberg,Bertil Samuelsson,Torsten Unge	15
9	Solid-phase library synthesis of reversed-statine type inhibitors of the malarial aspartyl proteases plasmepsin I and II 2003 ·Bioorganic & Medicinal Chemistry ·(unknown),Ingemar Kvarnström,Lotta Vrang,Elizabeth Hamelink,Anders Hallberg,Åsa Rosenquist,Bertil Samuelsson	14
10	Synthesis of Novel Thrombin Inhibitors. Use of Ring-Closing Metathesis Reactions for Synthesis of P2 Cyclopentene- and Cyclohexenedicarboxylic Acid Derivatives 2003 ·Journal of Medicinal Chemistry ·(unknown),Ingemar Kvarnström,Djordje Müsil,Ingemar Nilsson,Bertil Samuelsson	22
11	Synthesis of Potential Thrombin Inhibitors. Incorporation of Tartaric Acid Templates as P2 Proline Mimetics 2002 ·Bioorganic & Medicinal Chemistry ·(unknown),Jonas Brånalt,Ingemar Kvarnström,Ingemar Nilsson,Djordje Müsil,Bertil Samuelsson	9
12	Synthesis of Enantiomerically Pure Bis(hydroxymethyl)-Branched Cyclohexenyl and Cyclohexyl Purines as Potential Inhibitors of HIV 1996 ·The Journal of Organic Chemistry ·(unknown),Ingemar Kvarnström,Björn Classon,Bertil Samuelsson	26
13	Synthesis of [4,5-Bis(hydroxymethyl)-1,3-dioxolan-2-yl]nucleosides as Potential Inhibitors of HIV 1996 ·The Journal of Organic Chemistry ·Jonas Brånalt,Ingemar Kvarnström,Björn Classon,Bertil Samuelsson	16
14	Synthesis of [4,5-Bis(hydroxymethyl)-1,3-dithiolan-2-yl]nucleosides as Potential Inhibitors of HIV¹ 1996 ·The Journal of Organic Chemistry ·Jonas Brånalt,Ingemar Kvarnström,Björn Classon,Bertil Samuelsson	7
15	Synthesis of [4,5-Bis(hydroxymethyl)-1,3-oxathiolan-2-yl]nucleosides as Potential Inhibitors of HIV via Stereospecific Base-Induced Rearrangement of a 2,3-Epoxy Thioacetate¹ 1996 ·The Journal of Organic Chemistry ·Jonas Brånalt,Ingemar Kvarnström,Björn Classon,Bertil Samuelsson	17
16	Synthesis of 2′,3′-Dideoxy-3′-C-Hydroxymethyl Nucleosides Having the L-Configuration as Potential Inhibitors of HIV 1992 ·Nucleosides and Nucleotides ·Ingemar Kvarnström,(unknown),Carina Svensson,(unknown),(unknown),Björn Classon,Bertil Samuelsson	7
17	Synthesis of a Phosphonomethyl Analogue of 3'-Deoxy-3'-fluorothymidine. 1991 ·Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry ·(unknown),Björn Classon,Bertil Samuelsson,Ingemar Kvarnström,(unknown),Jan Becher,Allan E. Underhill	4
18	Synthesis of Some 3',5'-Dideoxy-5'-C-Phosphonomethyl Nucleosides. 1991 ·Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry ·(unknown),Björn Classon,Bertil Samuelsson,Ingemar Kvarnström,(unknown),(unknown),(unknown)	6
19	Synthesis of 1D-2-O- and 1D-5-O-(α-D-galactopyranosyl)-4-O-methyl-chiro-inositol: preference for equatorial hydroxyl groups in the imidate galactosylation procedure 1981 ·Carbohydrate Research ·Per J. Garegg,Ingemar Kvarnström	7
20	The Orthoester Glycosylation Method. Part II. Variation in the Anomeric Composition of the Product with Aglycone Basicity and Steric Accessibility. 1977 ·Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry ·Per J. Garegg,Ingemar Kvarnström,Per M. Boll,(unknown),Curt R. Enzell,Jan-Erik Berg,Anne‐Marie Pilotti	16

About Ingemar Kvarnström

Ingemar Kvarnström is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 64 papers that have together received 1.4k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (30 papers), Carbohydrate Chemistry and Synthesis (23 papers) and HIV Research and Treatment (19 papers). The work is most often cited by research in Organic Chemistry (874 citations), Virology (134 citations) and Infectious Diseases (277 citations). Ingemar Kvarnström has collaborated with scholars based in Sweden, Canada and Germany. Frequent co-authors include Per J. Garegg, Bertil Samuelsson, Björn Classon, Bengt Lindberg, Stefan C. T. Svensson, Anders Hallberg, U. Helena Danielson, Anders Karlén, Åsa Rosenquist and Gunilla Niklasson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact